Cipla is currently trading at Rs. 317.05, up by 3.15 points or 1.00% from its previous closing of Rs. 313.90 on the BSE.
The scrip opened at Rs. 317.95 and has touched a high and low of Rs. 319.90 and Rs. 311.95 respectively. So far 91,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 359.00 on 07-Feb-2012 and a 52 week low of Rs. 273.60 on 06-Sep-2011.
Last one week high and low of the scrip stood at Rs. 325.85 and Rs. 311.95 respectively. The current market cap of the company is Rs. 25,456 crore.
The promoters holding in the company stood at 36.80% while Institutions and Non-Institutions held 33.50% and 29.60% respectively.
Drug-maker, Cipla has posted a 16% year-on-year increase in net profit to Rs 269.91 crore for the quarter ended December 31, 2011. The company’s net profit for the third quarter last fiscal stood at Rs 232.69 crore.
The company’s net sales increased by 14% to Rs 1,711.47 crore in the third quarter of FY12 from Rs 1,501.36 crore in the three months ended December 31, 2010.
For the nine months ended December 31, 2011, the company's net profit amounted to Rs 832.22 crore and its net sales totaled Rs 4,993.63 crore.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1464.85 |
Dr. Reddys Lab | 5955.65 |
Cipla | 1477.15 |
Zydus Lifesciences | 1050.35 |
Lupin | 1603.55 |
View more.. |